Articles from FUJIFILM Corporation

FUJIFILM Corporation will present the company’s latest research findings at SPIE Advanced Lithography + Patterning 2026 (SPIE 2026), taking place February 22-26, 2026, in San Jose, California. The international conference is organized by SPIE, the international society for optics and photonics.

FUJIFILM Corporation today announced that its U.S.-based subsidiary for semiconductor materials, FUJIFILM Electronic Materials U.S.A., Inc. (Fujifilm), will participate in “SEMICON West 2025”, an international exhibition of semiconductor manufacturing equipment and materials, to be held in Phoenix, Arizona, from October 7-9, 2025, where it will highlight its broad portfolio of advanced high-purity chemicals & semiconductor materials.

FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced that the company has appointed Brian O’Donnelly as its Corporate Vice President, strengthening global leadership to drive growth in the Electronic Materials Business. He will continue serving as the President and CEO of FUJIFILM Electronic Materials USA, Inc., Senior Deputy General Manager of the Electronic Materials Business Division, FUJIFILM Corporation and Global Vice President of FUJIFILM Electronic Materials.

FUJIFILM Corporation announces the successful validation of the cancer cell-targeting potential of its peptide-oligonucleotide conjugates. This validation resulted from combining oligonucleotides with cyclic peptides developed from Fujifilm’s proprietary peptide library, which contains trillions of variants. This research achievement will be presented at TIDES USA, an exhibition to be held from May 19 to 22, 2025, in San Diego (poster number: 35).